CU Anschutz Wins FDA Clearance for CAR T Cancer Trial
Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...
Cancer Treatment
Advertisement
Johnson & Johnson Gains CE Mark for ACUVUE OASYS MAX
Limerick, Ireland, September 10, 2026 Johnson & Johnson has announced that it has received CE Marking for ACUVUE OASYS...
Marengo Completes STARt-001 Enrollment, Strengthens Team
Cambridge, Massachusetts, September 9, 2026 Marengo Therapeutics has completed enrollment in the monotherapy cohorts of its Phase 1/2 STARt-001...
Harbour BioMed Partner Solstice Oncology Raises $225M
Shanghai, China, September 10, 2026 Solstice Oncology, a partner of Harbour BioMed, has announced a $225 million Series A...
FDA Grants Accelerated Approval to Etcamah for Breast Cancer
Silver Spring, Maryland, USA, September 4, 2026 The U.S. Food and Drug Administration (FDA) has granted accelerated approval to...
Advertisements
FDA Approves Zanvastro as First Alexander Disease Drug
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has approved Zanvastro (zilganersen) injection...
Cipla Partners with Qilu on Keytruda Biosimilar
Mumbai, India and Warren, New Jersey, USA, September 3, 2026 Cipla Limited, through its wholly owned subsidiary InvaGen Pharmaceuticals...
Veloxis Begins Phase 2 Trial of Pegrizeprument
Research Triangle Park, North Carolina, August 31, 2026 Veloxis Pharmaceuticals, Inc. announced that the first patient has been dosed...
Lilly to Acquire Merida in $2.875B Immunology Deal
Indianapolis, Indiana, and Cambridge, Massachusetts, August 31, 2026 Eli Lilly and Company and Merida Biosciences, Inc. announced a definitive...
BeOne Medicines Expands U.S. Cancer Access and Manufacturing
SAN CARLOS, Calif., August 31, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company,...
Advertisement
